| Ticker Details |
|
OmniAb, Inc.
|
| IPO Date: |
September 30, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$324.74M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.11 | 3.39%
|
| Avg Daily Range (30 D): |
$0.13 | 5.29%
|
| Avg Daily Range (90 D): |
$0.09 | 4.42%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.42M |
| Avg Daily Volume (30 D): |
.46M |
| Avg Daily Volume (90 D): |
.47M |
| Trade Size |
| Avg Trade Size (Sh.): |
120 |
| Avg Trade Size (Sh.) (30 D): |
97 |
| Avg Trade Size (Sh.) (90 D): |
123 |
| Institutional Trades |
| Total Institutional Trades: |
121 |
| Avg Institutional Trade: |
$1.54M |
| Avg Institutional Trade (30 D): |
$1.3M |
| Avg Institutional Trade (90 D): |
$1.41M |
| Avg Institutional Trade Volume: |
.54M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.59M |
| Avg Closing Trade (30 D): |
$1.3M |
| Avg Closing Trade (90 D): |
$1.2M |
| Avg Closing Volume: |
476.1K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$-.06
|
$-.11
|
$-.57
|
|
Diluted EPS
|
$-.06
|
$-.11
|
$-.57
|
|
Revenue
|
$14.43M
|
$8.38M
|
$18.67M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-7.71M
|
$-14.18M
|
$-64.78M
|
|
Operating Income / Loss
|
$-7.83M
|
$-15.77M
|
$-68.97M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$M
|
$-3.01M
|
$-2.07M
|
|
PE Ratio
|
|
|
|
|
|
|